The Global Joint Pain Injections Market is Expected to Generate

Portland, OR, Nov. 15, 2022 (GLOBE NEWSWIRE) — A new business intelligence report released by Allied Market Research, the Joint pain injections market The size raised $6.3 billion in 2021 and is expected to generate $13.2 billion by 2031, growing at a CAGR of 7.7% from 2022 to 2031. The report provides an in-depth analysis of the development of market dynamics, major segments, value chain, competitive scenario and regions. countryside. This research offers valuable guidance for key players, investors, shareholders, and startups to design sustainable growth strategies and gain competitive advantage in the market.

Download a free sample report: https://www.alliedmarketresearch.com/request-sample/31909

Report coverage and details:

Report cover Details
Forecast period 2022–2031
Market size in 2021 $6.3 billion
Market size in 2031 $13.2 billion
CAGR 7.7%
Number of pages in the report 310
Segments Covered Injection Type, Joint Type, Distribution Channel and Region.
Drivers Increase in elderly population
High prevalence of obese population
Increased prevalence of osteoarthritis and rheumatoid arthritis
Growing need for affordable treatments for different types of arthritis
Rise in demand for joint pain injections due to increased prevalence of accidental injuries resulting in joint pain
Opportunities Research and development activities to invent more effective treatment options, including single injection therapy, platelet-rich plasma, prolotherapy, autologous conditioned serum, and plasma matrix therapy
Constraints Expensive treatment


Covid-19 scenario:

  • The outbreak of the COVID-19 pandemic negatively impacted the growth of the global joint pain injections market as it witnessed a decline in the sales of joint pain injections.
  • Many key players in the market have witnessed decline in revenue from joint pain injection segments primarily due to declining number of patient visits to hospitals, reallocation of healthcare resources, and effect on the supply chain around the world.
  • However, with the ease of restrictions, the demand for injections for joint pain is likely to increase after the pandemic.

The research provides a detailed segmentation of the global joint pain injection market on the basis of type, joint injection type, distribution channel and region. The report discusses the segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize based on the most revenue-generating and fastest-growing segments mentioned in the report.

Purchase order : https://www.alliedmarketresearch.com/purchase-enquiry/31909

Based on injection type, the interleukin inhibitors segment held the highest share in 2031, accounting for more than half of the global joint pain injections market. However, the hyaluronic acid injections segment is expected to register the highest CAGR of 14.7% from 2022 to 2031.

Based on joint type, the knee and ankle segment accounted for the highest share in 2021, contributing nearly two-fifths of the global joint pain injections market, and is expected to maintain its revenue lead. during the forecast period. However, the hip joint segment is expected to show the highest CAGR of 8.8% from 2022 to 2031.

Based on distribution channel, pharmacy and retail drugstore segment accounted for the highest share in 2021, holding more than half of the global joint pain injections market, and is expected to maintain its leading status over the course of 2021. the forecast period. However, the online vendor segment is expected to grow at the highest CAGR of 10.3% during the forecast period.

Based on region, North America held the largest share in 2021, contributing more than two-fifths of the global joint pain injections market share, and is expected to maintain its dominant share in terms of revenue in 2031. Also, Asia-Pacific region is expected to show the fastest CAGR of 9.5% during the forecast period. The research also analyzes regions such as Europe and LAMEA.

Key Players of Global Joint Pain Injections Market Analyzed in Research Include Abbvie Inc, Anika Therapeutics, Bioventus, Eli Lilly and Company, Ferring Pharmaceuticals Inc., PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.), Pfizer Inc., Sanofi SA , Teva Pharmaceuticals, Zimmer Biomet.

The report provides an in-depth analysis of these key players in the global Joint Pain Injections Market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements and others to increase their market share and maintain dominant shares in different regions. The report is valuable for highlighting the business performance, operating segments, product portfolio, and strategic moves of market players to present the competitive scenario.


Reports on trends in the healthcare industry (book now with 10% discount):

Scaffolding Technology Market By Product Type (Natural Scaffold, Synthetic Scaffold), By Type (Macroporous Scaffolds, Microporous Scaffolds, Nanoporous Scaffolds, Solid Scaffolds), By Application (Cancer Cell Research, Stem Cell Research, Drug Discovery, Regenerative Medicine) , by End User (Biotech and Pharmaceutical Companies, Contract Research Laboratories, Academic Institutes): Global Opportunities Analysis and Industry Forecast, 2021-2031

US home medical equipment market By Functionality (Therapeutic Equipment, Patient Monitoring Equipment, and Patient Mobility Aids and Support Equipment) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Retailers): Opportunity Analysis and Forecast industry, 2020-2030

pet diagnostics market By technology (clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, others), by application (clinical pathology, bacteriology, virology, parasitology, other applications), by animal type (dogs, cats, others), By End User (Diagnostic Laboratories, Veterinary Hospitals & Clinics, Point-of-Care & In-House Testing, Research Institutes & Universities): Global Opportunities Analysis and Industry Forecast, 2021-2031

Healthcare Gamification Market By Game Type (Exercise Games, Serious Games, Casual Games), By Application (Education, Therapeutic, Prevention), By End User (Business-Based, Consumer-Based): Global Opportunity Analysis and Growth Forecast industry, 2021-2031

Fertility Testing Market by product (ovulation predictor kits, fertility monitors, and male fertility testing products), how to buy (over-the-counter and prescription), application (female fertility testing and male fertility testing), and user (Home Care Facilities and Hospitals/Fertility Clinics): Global Opportunities Analysis and Industry Forecast, 2021-2030


About Us

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “Market research reportsand “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.


        

About Myra R.

Check Also

Ellis Wins Another Football Victory – Davie County Enterprise Record

Ellis scores another football victory Posted 7:26 p.m. on Wednesday, November 2, 2022 By Brian …